These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8116307)

  • 1. [S-phase fraction and proportion of cells with high DNA content as prognostic factors of lymph node negative breast cancer].
    Wagner T; Adler A; Kubista E
    Wien Klin Wochenschr; 1993; 105(24):712-4. PubMed ID: 8116307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DNA content analysis of breast cancer cells recognized by monoclonal antibody].
    Zhu LW
    Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):347-50. PubMed ID: 8174478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group.
    Baldetorp B; Stål O; Ahrens O; Cornelisse C; Corver W; Falkmer U; Fernö M
    Cytometry; 1998 Dec; 33(4):385-93. PubMed ID: 9845432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors.
    Hermsen MA; Baak JP; Meijer GA; Weiss JM; Walboomers JW; Snijders PJ; van Diest PJ
    J Pathol; 1998 Dec; 186(4):356-62. PubMed ID: 10209483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA cytometry in renal cell carcinoma.
    Nenning H; Rassler J; Minh DH
    Gen Diagn Pathol; 1996 Mar; 141(3-4):243-7. PubMed ID: 8705789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of flow cytometry for metastatic potential in breast cancer.
    Schmidt H; Wei JP; Yeh KA
    Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
    Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
    Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.
    Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Wright S; Baldetorp B
    Clin Lab Med; 2001 Dec; 21(4):875-95, x. PubMed ID: 11770293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer.
    Velanovich V
    Am Surg; 1997 Apr; 63(4):330-3. PubMed ID: 9124752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
    Friberg LG; Norén H; Delle U
    Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
    Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
    Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry in node-positive breast cancer: cancer and leukemia group B protocol 8869.
    Kute TE; Quadri Y; Muss H; Zbieranski N; Cirrincione C; Berry DA; Barcos M; Thor AP; Liu E; Koerner F
    Cytometry; 1995 Dec; 22(4):297-306. PubMed ID: 8749780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.
    Lackowska B; Niezabitowski A; Ryś J; Skołyszewski J; Stelmach A; Gruchała A; Jaszcz-Gruchała A
    Pol J Pathol; 2003; 54(2):101-10. PubMed ID: 14575418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction].
    Chassevent A; Jourdan ML; Ferrero-Poüs M; Colonna M; Romain S; Spyratos F; Roth H; Bolla M
    Bull Cancer; 1999; 86(7-8):685-91. PubMed ID: 10477386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.